Peter Jones

38 results.

April 11, 2017 VARI chief scientist joins elite ranks of American Academy of Arts and Sciences

Peter Jones, Ph.D., D.Sc., is one of 228 new members elected to this year’s class of the

March 27, 2017 Van Andel Research Institute installs world-class microscopes to enable discovery of the molecular basis of disease

GRAND RAPIDS, Mich. (March 28, 2017)—Van Andel Research Institute (VARI) is now home to one of the world’s most powerful microscopes—one that images life’s building…

February 2, 2017 In their own words: The most exciting advances in cancer research

In honor of World Cancer Day on Saturday, we asked our scientists and collaborators a simple question—what do you think is…

January 10, 2017 Making an early impact: Three questions for Dr. Rochelle Tiedemann

The long road from student to independent scientist doesn’t necessarily end with earning a doctoral degree. Just as physicians complete a residency after finishing medical…

November 15, 2016 Van Andel Institute hosts event highlighting women’s health: Experts share information, insight on women’s cancer

GRAND RAPIDS, Mich. (Nov. 16, 2016)—Van Andel Institute (VAI) today held “A Conversation About Women’s Health Hosted by Carol Van Andel: Common Cancers Affecting Women,”…

August 28, 2016 Vitamin C may boost effectiveness of acute myeloid leukemia treatment

EDITOR’S NOTE: Maintaining proper nutrition is an important part of cancer therapy. Patients are urged to consult their doctors before making any change to their…

May 2, 2016 Van Andel Institute scientist elected to National Academy of Sciences to advise nation on medical and epigenomic policy and direction

GRAND RAPIDS, Mich. (May 3, 2016)—Van Andel Research Institute (VARI) Chief Scientific Officer Peter Jones, Ph.D., D.Sc., today joined…

January 27, 2016 Phase II colorectal cancer clinical trial first to receive support, scientific oversight from Van Andel Research Institute–Stand Up To Cancer Epigenetics Dream Team

GRAND RAPIDS, Mich. (Jan. 28, 2016)—The first clinical trial to move forward as part of the Van Andel Research Institute–